Cargando…
Cabergoline therapy for Macroprolactinoma during pregnancy: A case report
BACKGROUND: We assessed the safety of Cabergoline therapy during pregnancy in a lady with hyperprolactinemia intolerant to Bromocriptine. CASE PRESENTATION: We report the case of a 31 year old lady who presented to us with uncontrolled hyperprolactinemia. A pituitary Macroadenoma was demonstrated by...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575245/ https://www.ncbi.nlm.nih.gov/pubmed/23110890 http://dx.doi.org/10.1186/1756-0500-5-606 |
_version_ | 1782259680954810368 |
---|---|
author | Shahzad, Hira Sheikh, Aisha Sheikh, Lumaan |
author_facet | Shahzad, Hira Sheikh, Aisha Sheikh, Lumaan |
author_sort | Shahzad, Hira |
collection | PubMed |
description | BACKGROUND: We assessed the safety of Cabergoline therapy during pregnancy in a lady with hyperprolactinemia intolerant to Bromocriptine. CASE PRESENTATION: We report the case of a 31 year old lady who presented to us with uncontrolled hyperprolactinemia. A pituitary Macroadenoma was demonstrated by MRI. Due to intolerance to Bromocriptine, Cabergoline was started. The patient improved and subsequently conceived. MRI in the second trimester demonstrated further reduction in the tumor size. It was decided to continue Cabergoline throughout pregnancy to ensure further reduction in tumor size until delivery and to hold Cabergoline during postpartum period to allow for an adequate interval of breastfeeding. At 37 weeks of gestation, the patient delivered a healthy baby. CONCLUSION: We were able to safely treat macroprolactinemia in our patient during pregnancy with cabergoline. This case report contributes to the relatively meager data available which advocates the safety of cabergoline therapy in pregnant hyperprolactinemic patients. |
format | Online Article Text |
id | pubmed-3575245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35752452013-02-19 Cabergoline therapy for Macroprolactinoma during pregnancy: A case report Shahzad, Hira Sheikh, Aisha Sheikh, Lumaan BMC Res Notes Case Report BACKGROUND: We assessed the safety of Cabergoline therapy during pregnancy in a lady with hyperprolactinemia intolerant to Bromocriptine. CASE PRESENTATION: We report the case of a 31 year old lady who presented to us with uncontrolled hyperprolactinemia. A pituitary Macroadenoma was demonstrated by MRI. Due to intolerance to Bromocriptine, Cabergoline was started. The patient improved and subsequently conceived. MRI in the second trimester demonstrated further reduction in the tumor size. It was decided to continue Cabergoline throughout pregnancy to ensure further reduction in tumor size until delivery and to hold Cabergoline during postpartum period to allow for an adequate interval of breastfeeding. At 37 weeks of gestation, the patient delivered a healthy baby. CONCLUSION: We were able to safely treat macroprolactinemia in our patient during pregnancy with cabergoline. This case report contributes to the relatively meager data available which advocates the safety of cabergoline therapy in pregnant hyperprolactinemic patients. BioMed Central 2012-10-31 /pmc/articles/PMC3575245/ /pubmed/23110890 http://dx.doi.org/10.1186/1756-0500-5-606 Text en Copyright ©2012 Shahzad et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Shahzad, Hira Sheikh, Aisha Sheikh, Lumaan Cabergoline therapy for Macroprolactinoma during pregnancy: A case report |
title | Cabergoline therapy for Macroprolactinoma during pregnancy: A case report |
title_full | Cabergoline therapy for Macroprolactinoma during pregnancy: A case report |
title_fullStr | Cabergoline therapy for Macroprolactinoma during pregnancy: A case report |
title_full_unstemmed | Cabergoline therapy for Macroprolactinoma during pregnancy: A case report |
title_short | Cabergoline therapy for Macroprolactinoma during pregnancy: A case report |
title_sort | cabergoline therapy for macroprolactinoma during pregnancy: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575245/ https://www.ncbi.nlm.nih.gov/pubmed/23110890 http://dx.doi.org/10.1186/1756-0500-5-606 |
work_keys_str_mv | AT shahzadhira cabergolinetherapyformacroprolactinomaduringpregnancyacasereport AT sheikhaisha cabergolinetherapyformacroprolactinomaduringpregnancyacasereport AT sheikhlumaan cabergolinetherapyformacroprolactinomaduringpregnancyacasereport |